GlassScriptPhysician profile
Neil P Patel
NPI 1902877145
$16,173.60
in general payments reported to CMS, 2019-2025
29 companies · $1,442 in 2025
The $1,442 reported for 2025 was more than what 79% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,533 · 2020: $1,533 · 2021: $3,905 · 2022: $4,087 · 2023: $2,266 · 2024: $1,407 · 2025: $1,442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,114.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $5,677.54 | 2019-2024 | Senza |
| Abbott Laboratories | $4,132.02 | 2019-2025 | Proclaim, Eterna |
| Relievant Medsystems, INC. | $1,128.40 | 2021-2023 | Intracept |
| Genesys Orthopedics Systems, L.L.C. | $1,096.87 | 2021 | |
| Globus Medical, INC. | $590.03 | 2025 | Senza, Omnia, Vyrsa V1 |
| Collegium Pharmaceutical, INC. | $546.84 | 2019-2024 | Belbuca, Xtampza |
| Curonix LLC | $537.51 | 2022-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $426.47 | 2020-2025 | Intracept, Intracept Rf Probe |
| Si-Bone, INC. | $384.44 | 2019-2021 | |
| Abbvie INC. | $197.35 | 2022-2023 | |
| Saluda Medical Americas, INC. | $139.08 | 2023-2024 | Evoke, Evoke Scs |
| Ucb, INC. | $135.71 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $129.45 | 2019-2024 | Tezspire |
| Esperion Therapeutics, INC. | $125.00 | 2020 | |
| Allergan, INC. | $123.66 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $107.54 | 2021-2025 | Percept PC Brainsense |
| Novo Nordisk INC | $104.15 | 2025 | |
| Mml US, INC. | $89.57 | 2025 | Reactiv8 |
| Johnson & Johnson Surgical Vision, INC. | $85.85 | 2020 | |
| Medtronic USA, INC. | $73.53 | 2019-2020 | |
| Stimwave Technologies Incorporated | $63.10 | 2020-2021 | |
| Amgen INC. | $55.50 | 2019 | |
| Integra Lifesciences Corporation | $47.09 | 2022 | |
| Nalu Medical, INC. | $43.79 | 2021 | |
| Pfizer INC. | $43.07 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $33.82 | 2021-2022 | |
| Astellas Pharma US INC | $25.51 | 2020 | |
| Baudax Bio INC. | $16.83 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.